Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CGON will rise by +9.28% over the next 2 Weeks and hit $66.98 by Monday, March 23, 2026. In that time frame, CGON's share price is expected to range between $65.26 and $68.76.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 23, 2026 | 65.26 | 66.98 | 68.76 |
| Mar 20, 2026 | 64.14 | 65.78 | 67.53 |
| Mar 19, 2026 | 63.37 | 64.94 | 66.51 |
| Mar 18, 2026 | 64.16 | 65.90 | 67.39 |
| Mar 17, 2026 | 64.13 | 65.63 | 67.13 |
| Mar 16, 2026 | 63.02 | 64.58 | 66.21 |
| Mar 13, 2026 | 61.80 | 63.39 | 64.97 |
| Mar 12, 2026 | 60.84 | 62.54 | 64.15 |
| Mar 11, 2026 | 61.97 | 63.50 | 64.97 |
| Mar 10, 2026 | 61.74 | 63.23 | 64.85 |
CGON shares rose +2.46% in Tuesday, March 10, 2026's trading session, rising from a previous close of $61.29 to move at $62.80. The stock demonstrated notable intraday movement (see CGON's key stats for a full breakdown), fluctuating between $60.23 and $63.89, a +6.09% trading range. While recent weeks have seen some volatility, CGON has managed to secure a +7.70% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.44M shares changing hands, 194.12K more than the previous session. This amounted to $90.19M in total market activity.
Will CGON Continue Its Upward Trend?
According to analyst ratings and projections for CGON, CG Oncology, Inc. Common stock shares are anticipated to increase by +8.67%, potentially reaching $68.76 per share by March 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for CGON. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the CGON stock forecast, now is a good time to buy CGON stock because its current trading price is -6.24% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CGON covering social and institutional perspectives.
CGON Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CGON's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 65.28% to 69.74%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 61.78%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 59.32%, maintains a neutral outlook for the long term. Insights into CGON's shareholder base show how institutional investors are positioning themselves during these momentum shifts
CG Oncology Common stock Short-Term Forecasts
CGON Forecast For Next 5 Days
Our algorithm anticipates CG Oncology Common stock (CGON) stock could hit $61.73 by Mar 17, 2026. This represents a -1.71% rise from today's price, following a +1.81% change over the past five days.
CGON Forecast For Next 30 Days
Based on analysis of market trends, the outlook for CG Oncology, Inc. Common stock (CGON) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $60.54, which would mean a -3.60% decrease from the current price of $62.80. Projections for this period range from a high of $67.53 to a low of $52.28.
CGON Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for CG Oncology Common stock's price over the next three months point to a drop. CGON stock is expected to peak at $65.91 on Apr 23, 2026 before potentially dipping to $54.71 on Jun 01, 2026. On average, CGON is likely to trade around $61.11 in the coming 90 days.
CG Oncology Common stock Stock Forecast 2025
Based on our predictive models, CG Oncology Common stock (CGON) is expected to trade between $54.71 and $70.79 throughout 2026. This would result in an average price of $62.42, potentially offering investors a -0.61% return from current levels.
CG Oncology, Inc. Common stock Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, CG Oncology, Inc. Common stock (CGON) is positioned to show a strong performance in March 2026. The price is predicted to move between $57.77 and $65.73, settling at an average of $62.03. This could translate to a -1.23% loss.
April 2026
Based on current market signals, CG Oncology, Inc. Common stock is projected to trend april 2026. We forecast a trading range from $56.92 to $65.91, with a likely average price of $61.73. Investors could expect a potential return of -1.70%.
May 2026
Our predictive algorithms indicate CG Oncology, Inc. Common stock stock may see a shift in May 2026. The expected range spans $55.33–$64.99, with an average target of $60.59. This represents a cautious outlook and a possible loss of -3.52%.
June 2026
Analyzing established trends, CG Oncology, Inc. Common stock looks set to move in June 2026. Projections place the stock between $54.71 and $65.54, averaging around $61.00. This suggests a -2.87% loss from current levels.
July 2026
Market indicators suggest CG Oncology, Inc. Common stock could experience notable changes during July 2026. Prices could fluctuate within $58.52 to $70.16, with a midpoint forecast of $63.60. The stock might deliver a +1.27% gain.
August 2026
Forecasting for August 2026, models estimate that CG Oncology, Inc. Common stock may undergo key fluctuations. If trends hold, the stock might trade between $58.47 and $67.34, averaging $63.11. This signals a positive trajectory with potential returns around +0.49%.
September 2026
According to our latest forecast models, CG Oncology, Inc. Common stock (CGON) is positioned to show a strong performance in September 2026. The price is predicted to move between $58.52 and $67.00, settling at an average of $62.83. This could translate to a +0.05% gain.
October 2026
Based on current market signals, CG Oncology, Inc. Common stock is projected to trend october 2026. We forecast a trading range from $55.50 to $70.79, with a likely average price of $61.38. Investors could expect a potential return of -2.26%.
November 2026
Our predictive algorithms indicate CG Oncology, Inc. Common stock stock may see a shift in November 2026. The expected range spans $56.59–$70.58, with an average target of $62.76. This represents a cautious outlook and a possible loss of -0.06%.
December 2026
Analyzing established trends, CG Oncology, Inc. Common stock looks set to move in December 2026. Projections place the stock between $58.93 and $70.79, averaging around $64.81. This suggests a +3.20% gain from current levels.
January 2027
Market indicators suggest CG Oncology, Inc. Common stock could experience notable changes during January 2027. Prices could fluctuate within $59.52 to $68.02, with a midpoint forecast of $63.88. The stock might deliver a +1.72% gain.
February 2027
Forecasting for February 2027, models estimate that CG Oncology, Inc. Common stock may undergo key fluctuations. If trends hold, the stock might trade between $59.71 and $67.87, averaging $63.98. This signals a positive trajectory with potential returns around +1.88%.
March 2027
According to our latest forecast models, CG Oncology, Inc. Common stock (CGON) is positioned to show a strong performance in March 2027. The price is predicted to move between $59.50 and $67.00, settling at an average of $63.06. This could translate to a +0.41% gain.
CGON's history of dividends and stock splits also plays a role in long-term investor confidence.